Schramel FMNH - Search Results

1

Comparing survival predicted by the diagnosis-specific Graded Prognostic Assessment (DS-GPA) to actual survival in patients with 1-10 brain metastases treated with stereotactic radiosurgery.

Nagtegaal SHJ, Claes A, Suijkerbuijk KPM, Schramel FMNH, Snijders TJ, Verhoeff JJC. Nagtegaal SHJ, et al. Among authors: schramel fmnh. Radiother Oncol. 2019 Sep;138:173-179. doi: 10.1016/j.radonc.2019.06.033. Epub 2019 Jul 11. Radiother Oncol. 2019. PMID: 31302392

2

Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.

Kastelijn EA, El Sharouni SY, Hofman FN, Van Putte BP, Monninkhof EM, Van Vulpen M, Schramel FM. Kastelijn EA, et al. Anticancer Res. 2015 Oct;35(10):5607-14. Anticancer Res. 2015. PMID: 26408733

3

Changes in Pulmonary Function After Stereotactic Body Radiotherapy and After Surgery for Stage I and II Non-small Cell Lung Cancer, a Description of Two Cohorts.

Alberts L, El Sharouni SY, Hofman FN, Van Putte BP, Tromp E, Van Vulpen M, Kastelijn EA, Schramel FM. Alberts L, et al. Anticancer Res. 2015 Dec;35(12):6773-9. Anticancer Res. 2015. PMID: 26637895

4

Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands.

van der Linden N, Bongers ML, Coupé VMH, Smit EF, Groen HJM, Welling A, Schramel FMNH, Uyl-de Groot CA. van der Linden N, et al. Among authors: schramel fmnh. Clin Lung Cancer. 2017 Sep;18(5):e341-e347. doi: 10.1016/j.cllc.2015.11.011. Epub 2015 Nov 30. Clin Lung Cancer. 2017. PMID: 28347579

5

Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-Small Cell Lung Cancer.

Wolff HB, Alberts L, Kastelijn EA, Lissenberg-Witte BI, Twisk JW, Lagerwaard FJ, Senan S, El Sharouni SY, Schramel FMNH, Coupé VMH. Wolff HB, et al. Among authors: schramel fmnh. J Thorac Oncol. 2018 May;13(5):689-698. doi: 10.1016/j.jtho.2018.01.021. Epub 2018 Jan 31. J Thorac Oncol. 2018. PMID: 29391288 Free article.

6

Predicting Incomplete Resection in Non-Small Cell Lung Cancer Preoperatively: A Validated Nomogram.

Rasing MJA, Peters M, Moreno AC, Hofman EFN, Herder GJM, Welvaart PWN, Schramel FMNH, Lodeweges JE, Lin SH, Verhoeff JJC, van Rossum PSN. Rasing MJA, et al. Among authors: schramel fmnh. Ann Thorac Surg. 2021 Mar;111(3):1052-1058. doi: 10.1016/j.athoracsur.2020.05.165. Epub 2020 Jul 31. Ann Thorac Surg. 2021. PMID: 32739254 Free article.

7

Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study.

Rasing MJA, Peters M, Aarts MJ, Herder GJM, van Lindert ASR, Schramel FMNH, van der Meer FS, Verhoeff JJC, van Rossum PSN. Rasing MJA, et al. Among authors: schramel fmnh. Curr Probl Cancer. 2022 Feb;46(1):100784. doi: 10.1016/j.currproblcancer.2021.100784. Epub 2021 Aug 14. Curr Probl Cancer. 2022. PMID: 34456061 Free article.

8

Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.

El Sharouni SY, Kal HB, Barten-Van Rijbroek A, Struikmans H, Battermann JJ, Schramel FM. El Sharouni SY, et al. Anticancer Res. 2009 Dec;29(12):5219-24. Anticancer Res. 2009. PMID: 20044639 Free article.

9

Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.

Groen HJ, Sietsma H, Vincent A, Hochstenbag MM, van Putten JW, van den Berg A, Dalesio O, Biesma B, Smit HJ, Termeer A, Hiltermann TJ, van den Borne BE, Schramel FM. Groen HJ, et al. J Clin Oncol. 2011 Nov 10;29(32):4320-6. doi: 10.1200/JCO.2011.35.5214. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990410 Clinical Trial.

10

Feasibility of Concomitant Chemoradiotherapy in Daily Practice for Patients with NSCLC Stage III.

VAN DER Meer FS, Schramel FM, VAN Vulpen M, El Sharouni SY. VAN DER Meer FS, et al. Anticancer Res. 2016 Sep;36(9):4673-6. doi: 10.21873/anticanres.11019. Anticancer Res. 2016. PMID: 27630311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page